How to buy Omeros Corporation stock (OMER)

Omeros Corporation is a biotechnology business based in the US. Omeros Corporation shares (OMER) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $11.68 – an increase of 13.29% over the previous week. Omeros Corporation employs 198 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Omeros Corporation stock

Buy Omeros Corporation stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Omeros Corporation stock price (NASDAQ: OMER)

Use our graph to track the performance of OMER stocks over time.

Omeros Corporation shares at a glance

• Key figures

Information last updated 2024-12-25.

Latest market close	$11.68
52-week range	$2.61 - $13.60
50-day moving average more info button	$7.17
200-day moving average more info button	$4.71
Wall St. target price	$43.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-3.14

Is it a good time to buy Omeros Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Omeros Corporation price performance over time

Historical closes compared with the close of $10.46 from 2024-12-26

1 week (2024-12-20)	1.45%
1 month (2024-11-29)	-7.84%
3 months (2024-09-27)	166.84%
6 months (2024-06-28)	157.64%

1 year (2023-12-28)	197.16%
2 years (2022-12-28)	343.22%
3 years (2021-12-28)	51.81%
5 years (2019-12-27)	15

Omeros Corporation financials

Gross profit TTM	$-71,397,000
Return on assets TTM	-26.87%
Return on equity TTM	-576.33%
Profit margin	0%
Book value	$-2.66
Market Capitalization more info button	$579.5 million

TTM: trailing 12 months

Omeros Corporation share dividends

We're not expecting Omeros Corporation to pay a dividend over the next 12 months.

Have Omeros Corporation's shares ever split?

Omeros Corporation's shares were split on a 1:1.96 basis on 1 October 2009 . So if you had owned 1.96 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Omeros Corporation shares – just the quantity. However, indirectly, the new 96% higher share price could have impacted the market appetite for Omeros Corporation shares which in turn could have impacted Omeros Corporation's share price.

Omeros Corporation share price volatility

Over the last 12 months, Omeros Corporation's shares have ranged in value from as little as $2.612 up to $13.6. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Omeros Corporation's is 1.476. This would suggest that Omeros Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Omeros Corporation overview

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases, including complement-mediated diseases, cancers, and addictive and compulsive disorders. The company's products under development include Narsoplimab (OMS721/MASP-2) that has completed pivotal trial for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); that is in Phase III clinical trial for the treatment of immunoglobulin A nephropathy (IgAN); and Phase II clinical trial to treat COVID-19. It also develops OMS1029 that is in phase I clinical trials for long-acting second-generation antibody targeting lectin pathway disorders; OMS906 that has completed phase II clinical trials for Paroxysmal nocturnal hemoglobinuria, complement 3 glomerulopathy, and other alternative pathway disorders; and OMS527 that is in phase I clinical trials for addictions and compulsive disorders, and movement disorders. In addition, the company's products under preclinical development comprise MASP-2, a pro-inflammatory protein target for the treatment of lectin pathway disorders; MASP-3 small-molecule inhibitors for alternative pathway disorders; and Adoptive T-Cell and Chimeric Antigen Receptor (CAR) T-Cell Therapies and Immunomodulators/Immunotoxins/Cancer Vaccines for the treatment of various cancers. Omeros Corporation was incorporated in 1994 and is headquartered in Seattle, Washington. .

Frequently asked questions

What percentage of Omeros Corporation is owned by insiders or institutions?
Currently 4.445% of Omeros Corporation shares are held by insiders and 43.677% by institutions. How many people work for Omeros Corporation?
Latest data suggests 198 work at Omeros Corporation. When does the fiscal year end for Omeros Corporation?
Omeros Corporation's fiscal year ends in December. Where is Omeros Corporation based?
Omeros Corporation's address is: The Omeros Building, Seattle, WA, United States, 98119 What is Omeros Corporation's ISIN number?
Omeros Corporation's international securities identification number is: US6821431029 What is Omeros Corporation's CUSIP number?
Omeros Corporation's Committee on Uniform Securities Identification Procedures number is: 682143102